COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,244 Articles (22,733 medRxiv, 8,511 bioRxiv)

Most recent first Previous |  Page 1085: Articles 10841-10850  | Next

No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination
Lu-Culligan, A., Tabachnikova, A., Tokuyama, M., Lee, H. J., Lucas, C., Silva Monteiro, V., Muenker, M. C., Mohanty, S., Huang, J., Kang, I., Dela Cruz, C., Farhadian, S., Campbell, M., Yildirim, I., Shaw, A., Ko, A., Omer, S., Iwasaki, A.
10.1101/2021.12.07.471539 — Posted: 2021-12-08
Insights on the mutational landscape of the SARS-CoV-2 Omicron variant
Miller, N. L., Clark, T., Raman, R., Sasisekharan, R.
10.1101/2021.12.06.471499 — Posted: 2021-12-08
Production of novel Spike truncations in Chinese hamster ovary cells
Minami, S. A., Jung, S., Huang, Y., Harris, B. S., Kenaston, M. W., Faller, R., Nandi, S., McDonald, K. A., Shah, P. S.
10.1101/2021.12.06.471489 — Posted: 2021-12-08
A proteomic perspective and involvement of cytokines in SARS-CoV-2 infection
Banu, S., Idris, M. M., Nagaraj, R.
10.1101/2021.12.06.471525 — Posted: 2021-12-08
Characterization of the interaction between SARS-CoV-2 Membrane Protein and Proliferating Cell Nuclear Antigen (PCNA) as a Potential Therapeutic Target
Zambalde, E. P., Mancini, M. C. S., Scudero, O. B., Pavan, I. C. B., Severi, M. B., Morelli, A. P., Amorim, M. R., dos Santos, K. B., Parise, P. L., Gois, M. M., Toledo-Teixeira, D. A., Mauad, T., Saldiva, P. H. N., Dolhnikoff, M., Proenca-Modena, J. L., Marques-Souza, H., Ventura, A. M., Simabuco, F. M.
10.1101/2021.12.06.471464 — Posted: 2021-12-08
The cellular characterisation of SARS-CoV-2 spike protein in virus-infected cells using Receptor Binding Domain-binding specific human monoclonal antibodies.
Chan, C. E.-Z., Ng, C.-G., Lim, A. P. C., Seah, S. G.-K., Chye, D. H., Wong, S. K. K., Lim, J.-H., Lim, V. Z.-Y., Lai, S. K., Wong, P.-S., Leong, K.-M., Liu, Y., Sugrue, R., Tan, B. H.
10.1101/2021.12.06.471528 — Posted: 2021-12-08
Metabolic dysregulation induces impaired lymphocyte memory formation during severe SARS-CoV-2 infection
Nguyen, H., Gurshaney, S., Alvarez, A. M., Ezhakunnel, K., Manalo, A., Huynh, T.-H., Le, N. -T., Lupu, D., Gardell, S.
10.1101/2021.12.06.471421 — Posted: 2021-12-08
Identifying protein sites contributing to vaccine escape via statistical comparisons of short-term molecular dynamics simulations
Rajendran, M., Ferran, M. C., Babbitt, G. A.
10.1101/2021.12.06.471374 — Posted: 2021-12-08
PROBABILITY OF HOSPITALIZATION AND DEATH AMONG COVID-19 PATIENTS WITH COMORBIDITY DURING OUTBREAKS OCCURRING IN MEXICO CITY.
Sifuentes-Osornio, J., Angulo-Guerrero, O., de Anda-Jauregui, G., Diaz-De-Leon-Santiago, J. L., Hernandez-Lemus, E., Benitez-Perez, H., Herrera, L. A., Lopez-Arellano, O., Revuelta-Herrera, A., Rosales-Tapia, A. R., Suarez-Tapia, M., Ruiz-Gutierrez, R., Sheinbaum-Pardo, C., Kershenobich, D.
10.1101/2021.12.07.21267287 — Posted: 2021-12-08
COVID-19 Vaccine Hesitancy Among Patients with Inflammatory Bowel Disease on Biologic Therapies; A cross-sectional study.
Shehab, M., Zurba, Y., Al Abdulsalam, A., Alfadhli, A., Elouali, S.
10.1101/2021.12.03.21267237 — Posted: 2021-12-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).